Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment
Moataz M. Reda, Worapol Ngamcherdtrakul, Natnaree Siriwon, Daniel S. Bejan, Sherif M. Reda, Ruijie Wang, Molly A. Nelson, Husam Y. Zaidan, N. Hoang, Akash Bindal, G. Mills, J. Gray, W. Yantasee